Peer Review History

Original SubmissionMay 24, 2022
Decision Letter - Baisong Lu, Editor

PONE-D-22-14986Disruption of T-box transcription factor eomesa results in abnormal development of median fins in Oujiang color common carp Cyprinus carpioPLOS ONE

Dear Dr. Ren,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================In addition to the issues raised by the two reviewers, the author should take care of the following issues:1) Potential off-targets of the four sgRNAs should be predicted and listed.2) Potential targeting of homologous genes (Eomesb) by the four sgRNAs should be examined by prediction. If there is a possibility of hitting these genes, design experiments (Surveyor assay or sanger sequencing) to check editing in those sites.3) Either increase the number of sanger sequencing clones or do NGS analysis.4) In Fig.2 and Fig.3, the authors should align all mutated sequences with the reference sequence.  Indicate PAM and sgRNA target sequence. 5) In table 1, the PAM sequences should be listed.6) The authors knocked out both genes and observed phenotypes. Comparing the observed phenotypes with those after knocking out only one gene should provide information on the roles of each gene in fin development. The authors should discuss this point in the paper.==============================

Please submit your revised manuscript by Aug 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Baisong Lu, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. 

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

The name of the colleague or the details of the professional service that edited your manuscript

A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

A clean copy of the edited manuscript (uploaded as the new *manuscript* file)”

3. Thank you for stating the following financial disclosure: 

"NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"This work was financially supported by the Open Project Foundation from Key Laboratory of Freshwater Aquaculture Genetic and Breeding of Zhejiang Province, Zhejiang Institute of Freshwater Fisheries (ZJK202112); Development of Genetic Improvement Technique for Ornamental Fish (D-8006-19-0166), and the SHOU&MSU Joint Research Center grant."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript, the author trying to design a certain kind of sgRNA sequence to disrupt two homologous genes (eomesa) in polyploidy fish. The innovation of the article is acceptable, but there are some problems needs to be solved.

(1) Detection of gene editing efficiency is an important for this article, but sanger sequencing is not that convincible and the sample size of 10 could not accurately reflect its effectiveness, next generation sequence is highly recommended to verify its efficiency.

(2) The SgRNA sequence design and optimization should be incorporated into the method. And the SgRNA's quality should be verified and supplemented into the manuscript.

(3) What caused the difference of gene editing efficiency between two injections. Will this difference have an impact on the later detection of gene editing efficiency? Please explain this difference in the discussion part.

(4) In this paper, only sequencing and topography methods were used to observe the effectiveness of Gene Editing efficiency, Immunofluorescence detection (IF) or Western Blot (WB) for target protein are highly recommended to supplement in the manuscript.

Reviewer #2: In the present manuscript, Shiying Song et al aim to define the roles of eomesa genes in the median fin development in color common carp. By using gene editing and Sanger sequencing experiments, they disrupted eomesa genes and showed that eomesa genes are essential for the development of median fins in Oujiang color common carp. The biggest issue with the manuscript is that it is primarily engaged in confirming the observations made by the other studies. The manuscript has not provided further insights into the underlying mechanisms.

1. In Figure 2b, the labeling should be the eomesa1 loci.

2. In Figure 4a, it is not clear to the reviewer whether the data of the eomesa mutant in zebrafish are from the literature or generated by the authors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers’ Comments

Reviewer 1:

In this manuscript, the author trying to design a certain kind of sgRNA sequence to disrupt two homologous genes (eomesa) in polyploidy fish. The innovation of the article is acceptable, but there are some problems needs to be solved.

Comment 1. Detection of gene editing efficiency is an important for this article, but Sanger sequencing is not that convincible and the sample size of 10 could not accurately reflect its effectiveness, next generation sequence is highly recommended to verify its efficiency.

Response: Thanks to the reviewer’s constructive suggestion. Unfortunately, due to the outbreak of COVID-19 pandemic, all the mosaic F0 fish raised at the farming base died. We checked the DNA samples stored in our lab and found only a little bit of DNA from 7 dpf larvae were remained. The quality and quantity of the remained DNA is not suit for NGS analysis. The detection of gene editing efficiency with NGS method could not be performed. We used the DNA for off-target analysis via PCR-TA clone sequencing method (see below. response to editor’s comment 2). NGS analysis is a good detection method that we have not used before. Recently, we did some gene editing work in other cultured fishes, we will try to use this method in gene editing detection. Thank you very much.

Comment 2. The SgRNA sequence design and optimization should be incorporated into the method. And the SgRNA's quality should be verified and supplemented into the manuscript.

Response: According to the reviewer’s suggestion, we inserted the sentences “To avoiding sgRNA off-target effects, all candidate target sequences were aligned onto the common carp reference genome with NCBI BLAST programme and screened with the criteria of core base (12 bases adjacent to PAM) mismatches = 0” into the section of “Materials and methods”. In the same paragraph, we described how to verify SgRNA's quality as “The quality of the sgRNAs was measured by electrophoresis and bright bands (actual size 119 bp) between 100 and 150 bp (50 bp DNA Ladder, Takara) were visible on 2% agarose gel. The concentration of the sgRNAs was further measured by NanoDrop 2000 (Thermo Scientific) and concentration of the sgRNAs was about 900 ng/μl.

Comment 3. What caused the difference of gene editing efficiency between two injections. Will this difference have an impact on the later detection of gene editing efficiency? Please explain this difference in the discussion part.

Response: In our lab, we mostly do gene editing work using the model fish zebrafish. This is the first gene editing work using the non-model fish common carp. As you known, the common carp is very different from zebrafish in the spawning frequency and it spawns once per year and its eggs have some difference with those of zebrafish in the size, viscosity, intensity of egg membrane and so on. We have no chance to practice injecting with the egg of common carp in advance. Thus, we were more skilled in the second injection experiment than in the first injection experiment. The proficiency in injection skill has an impact on the later detection of gene editing efficiency. As you see, the knockout efficiency in experiment performed at the second time was at least 4.0% higher than that in experiment at the first time. We added a sentence to explain this difference in the Discussion section as following “However, the knockout efficiency on 24 hpf embryos in experiment performed at the second time was at least 4.0% higher than that in experiment at the first time, which is probably due to improved injection skill at the second time.”

Comment 4. In this paper, only sequencing and topography methods were used to observe the effectiveness of gene editing efficiency, Immunofluorescence detection (IF) or Western Blot (WB) for target protein are highly recommended to supplement in the manuscript.

Response: Response: The most used methods to detect gene editing efficiency in zebrafish is the combination of endonuclease digestion and gel electrophoresis, and sequencing including Sanger sequencing for low throughput screening and NextGen sequencing for high throughput screening of multiple loci. Immunofluorescence detection (IF) or Western Blot (WB) are probably good methods to detect target protein level in model animals such as mouse or rat. However, even in the model fish zebrafish, the applicable antibodies are limited. Thus, to date, the detection methods of IF and WB are still difficult to apply into common carp.

Reviewer 2:

In the present manuscript, Shiying Song et al aim to define the roles of eomesa genes in the median fin development in color common carp. By using gene editing and Sanger sequencing experiments, they disrupted eomesa genes and showed that eomesa genes are essential for the development of median fins in Oujiang color common carp. The biggest issue with the manuscript is that it is primarily engaged in confirming the observations made by the other studies. The manuscript has not provided further insights into the underlying mechanisms.

Comment 1. In Figure 2b, the labeling should be the eomesa1 loci.

Response: We checked the Figure 2b again. The label is correct. We used the T1 site of eomesa2 locus as an example to show that many mutation types (insertion or deletion, or both) occurred.

Comment 2. In Figure 4a, it is not clear to the reviewer whether the data of the eomesa mutant in zebrafish are from the literature or generated by the authors.

Response: The phenotypic figures of wild type and eomesa mutant zebrafish were generated by our lab. We added several sentences into the section of Materials and methods as following “To compare the phenotype presented in mosaic F0 common carp with that in eomesa mutant zebrafish, the eomesafh105 mutant zebrafish were obtained from China Zebrafish Resource Center and the median fin phenotypes of several generation offsprings were observed” and one sentence into the section of Discussion as following “In our observation of median fin phenotypes of eomesa mutants”.

Response to Editor’s Comments

In addition to the issues raised by the two reviewers, the author should take care of the following issues:

Comment 1. Potential off-targets of the four sgRNAs should be predicted and listed.

Response: We predicted the potential off-targets of the four sgRNAs by using an CRISPR/Cas9 target online predictor CCTop with the default parameters of core length = 12, max. core mismatches = 2, max. total mismatches = 4. The results including efficacy score of each sgRNA and its targets and off-targets were listed in Supplemental Figure 2. The results of off-targets were further described in the section of Discussion.

Comment 2. Potential targeting of homologous genes (Eomesb) by the four sgRNAs should be examined by prediction. If there is a possibility of hitting these genes, design experiments (Surveyor assay or Sanger sequencing) to check editing in those sites.

Response: We checked the potential off-targets of the four sgRNAs predicted with CCTop. Indeed, among the four sgRNAs designed, the T3 sgRNA possibly targets the exonic regions of eomesb genes (eomesb1 and eomesb2) as there are three or four mismatches (Indicated with red rectangle in Supplemental Figure 2). We checked whether the exonic regions of eomesb genes (eomesb1 and eomesb2) were targeted by T3 sgRNA using the DNA samples of 10 larvae at 7 dpf stored at lab with PCR-TA clone sequencing method. The sequencing results showed that exonic regions of eomesb genes (eomesb1 and eomesb2) were not targeted by T3 sgRNA (The results were supplemented in Supplementary-materials-for-offtarget and discussed in the section of Discussion). Therefore, we infer that the abnormal development of median fins was not caused by the loss function of eomesb. We generated gene knockout zebrafish of emosb in previous study. It did not present any phenotypes related to fin development. We added these information and cited our published paper in Discussion.

Comment 3. Either increase the number of Sanger sequencing clones or do NGS analysis.

Response: Thank you for your good suggestion. We checked the DNA samples stored in our lab and found only a little bit of DNA from 7 dpf larvae were remained. The quality and quantity of the remained DNA is not suit for NGS analysis. We used the DNA for off-target analysis via PCR-TA clone sequencing method. NGS analysis is a good detection method that we have not used before. Recently, we did some gene editing work in other cultured fishes, we will try to use this method in gene editing detection. Thank you very much.

Comment 4. In Fig. 2 and Fig. 3, the authors should align all mutated sequences with the reference sequence. Indicate PAM and sgRNA target sequence.

Response: We aligned all mutated sequences with the reference sequences and indicated PAM and sgRNA target sequence. These results were listed in Supplemental Figure 3.

Comment 5. In table 1, the PAM sequences should be listed.

Response: We listed the PAM sequences for each target on eomesa1 and eomesa2.

Comment 6. The authors knocked out both genes and observed phenotypes. Comparing the observed phenotypes with those after knocking out only one gene should provide information on the roles of each gene in fin development. The authors should discuss this point in the paper.

Response: Thank your for your constructive suggestion. Unfortunately, due to the outbreak of COVID-19 pandemic, all the mosaic F0 fish raised at the farming base died. We could not obtain the offspring with knockout of only one gene and observe their phenotypes. We speculate that the functions of two eomesa genes are redundant and dosage-dependent on median fin development. The offspring with knockout of only single gene may have weak phenotype with median fin defect. We discussed this point in the paper.

Attachments
Attachment
Submitted filename: Response-to-Reviewers.docx
Decision Letter - Baisong Lu, Editor

Disruption of T-box transcription factor eomesa  results in abnormal development of median fins in Oujiang color common carp Cyprinus   carpio

PONE-D-22-14986R1

Dear Dr. Ren,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Baisong Lu, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Baisong Lu, Editor

PONE-D-22-14986R1

Disruption of T-box transcription factor eomesa results in abnormal development of median fins in Oujiang color common carp Cyprinus carpio  

Dear Dr. Ren:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Baisong Lu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .